title: Fibrates in the treatment of dyslipidemias--time for a reassessment.
authors.affiliation: Joslin Diabetes Center and Harvard Medical School, Boston, USA.
authors.forename: Allison B
authors.initials: AB
authors.lastname: Goldfine
authors.forename: Sanjay
authors.initials: S
authors.lastname: Kaul
authors.forename: William R
authors.initials: WR
authors.lastname: Hiatt
mesh_terms: D026683:Advisory Committees; D002318:Cardiovascular Diseases / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004359:Drug Therapy, Combination; D050171:Dyslipidemias / Q000188:drug therapy*; D011345:Fenofibrate / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011345:Fenofibrate